Cargando…
Pharmacologic Treatment and Management of Coronavirus Disease 2019
Over the last 2 years, there has been gradual and sustained progress toward our understanding of pharmacotherapy for coronavirus disease 2019 (COVID-19) as a result of large- and small-scale randomized controlled trials. Numerous new and repurposed treatments have been evaluated; some have demonstra...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Health Sciences Division
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828431/ https://www.ncbi.nlm.nih.gov/pubmed/35636904 http://dx.doi.org/10.1016/j.idc.2022.02.001 |
_version_ | 1784647843748773888 |
---|---|
author | Shumaker, Amy Hirsch Bhimraj, Adarsh |
author_facet | Shumaker, Amy Hirsch Bhimraj, Adarsh |
author_sort | Shumaker, Amy Hirsch |
collection | PubMed |
description | Over the last 2 years, there has been gradual and sustained progress toward our understanding of pharmacotherapy for coronavirus disease 2019 (COVID-19) as a result of large- and small-scale randomized controlled trials. Numerous new and repurposed treatments have been evaluated; some have demonstrated benefit in clinically important outcomes like mortality and hospitalization, and optimism for oral antiviral treatments is growing. Given the rapidly evolving landscape of COVID-19 treatments, frontline clinicians should use treatment and management guidelines to guide their approach to each patient, with the individual’s severity and location of illness in mind to appreciate the nuances in clinical evidence. |
format | Online Article Text |
id | pubmed-8828431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Health Sciences Division |
record_format | MEDLINE/PubMed |
spelling | pubmed-88284312022-02-10 Pharmacologic Treatment and Management of Coronavirus Disease 2019 Shumaker, Amy Hirsch Bhimraj, Adarsh Infect Dis Clin North Am Article Over the last 2 years, there has been gradual and sustained progress toward our understanding of pharmacotherapy for coronavirus disease 2019 (COVID-19) as a result of large- and small-scale randomized controlled trials. Numerous new and repurposed treatments have been evaluated; some have demonstrated benefit in clinically important outcomes like mortality and hospitalization, and optimism for oral antiviral treatments is growing. Given the rapidly evolving landscape of COVID-19 treatments, frontline clinicians should use treatment and management guidelines to guide their approach to each patient, with the individual’s severity and location of illness in mind to appreciate the nuances in clinical evidence. Elsevier Health Sciences Division 2022-06 2022-02-10 /pmc/articles/PMC8828431/ /pubmed/35636904 http://dx.doi.org/10.1016/j.idc.2022.02.001 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Shumaker, Amy Hirsch Bhimraj, Adarsh Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title | Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title_full | Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title_fullStr | Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title_full_unstemmed | Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title_short | Pharmacologic Treatment and Management of Coronavirus Disease 2019 |
title_sort | pharmacologic treatment and management of coronavirus disease 2019 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828431/ https://www.ncbi.nlm.nih.gov/pubmed/35636904 http://dx.doi.org/10.1016/j.idc.2022.02.001 |
work_keys_str_mv | AT shumakeramyhirsch pharmacologictreatmentandmanagementofcoronavirusdisease2019 AT bhimrajadarsh pharmacologictreatmentandmanagementofcoronavirusdisease2019 |